Author | Kathryn E. Beckermann, MD, PhD | OncLive

Author | Kathryn E. Beckermann, MD, PhD

Articles

Dr. Beckermann on Investigational Treatment Strategies in mRCC

February 04, 2020

Kathryn E. Beckermann, MD, PhD, discusses investigational treatment strategies in metastatic renal cell carcinoma.

Dr. Beckermann on Sequencing Strategies in mRCC

December 04, 2019

Kathryn E. Beckermann, MD, PhD, instructor of medicine, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, discusses sequencing strategies in metastatic renal cell carcinoma (mRCC).

Dr. Beckermann on TKI/Immunotherapy Combinations in mRCC

November 28, 2019

Kathryn E. Beckermann, MD, PhD, discusses treatment selection in metastatic renal cell carcinoma.

Biomarker Dilemma Persists With Immunotherapy in Bladder Cancer

May 15, 2018

The quest continues to identify a predictive biomarker of response to more precisely treat patients with checkpoint inhibitors that, while markedly beneficial to some patients, are not without their own costs and associated immune-related adverse effects.

x